Navigation Links
Cell Therapeutics, Inc. (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
Date:11/5/2008

SEATTLE, Nov. 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Tuesday, November 11th at 10:45 AM at the New York Palace Hotel.

The conference will also be webcast live with slides and available for replay after the presentation. The webcast can be accessed at http://www.celltherapeutics.com.

Rodman & Renshaw 10th Annual Healthcare Conference

CTI Presentation: Tuesday, November 11

10:45 AM EST/4:45 PM CET/7:45 AM PST

Audio webcast with slides at http://www.celltherapeutics.com

Media Contact: Investors Contact :

Cell Therapeutics, Inc. Cell Therapeutics, Inc.

Dan Eramian Ed Bell

T: 206.272.4343 T: 206.272.4345

F: 206.272.4434 F: 206.272.4434

Lindsey Jesch Logan E: invest@ctiseattle.com

T: 206.272.4347 http://www.celltherapeutics.com/investors

E: media@ctiseattle.com

http://www.celltherapeutics.com/press_room


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
2. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
3. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes
4. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
5. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
6. Zevalin Revenues Lead Cell Therapeutics, Inc.s First Quarter 2008 Financial Results
7. Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
8. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
9. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
10. Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes
11. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ws that 95 percent of radiation oncologists use ad...n tomography (FDG-PET), magnetic resonance imaging...T) for target delineation (to locate the tumor and... to an article in the December issue of the Journ... www.jacr.org ). , In defining the target, the ...
(Date:11/24/2009)...,Nov.24/PRNewswire-USNewswire/--OnFriday,November2...receivedafatalblowtotheheadduringatitleboutinPhila...effortstosavehislifewereconducted,hewasdeclaredbra...onprofitorganprocurementorganization(OPO)servingea...scontactedbythehospitalaspartofstandardclinicalpro...
(Date:11/24/2009)...24/PRNewswire/--Theholidayseasoncanbeatimefullofjo...e,especiallythoserecoveringfromaneatingdisorder,it...stfailuresandanxietyaboutanuncertainfuture.Familyg...ercanbechallengingandsometimesawkward. ,, "Inmy...toovereatingwiththefamily and duringtheholidayscan...
(Date:11/24/2009)...24/PRNewswire/-- Asyear-endapproaches,manyemploye...yearandnext.Tohelpyoutakeadvantageofthesespecialta...lystatThomsonReuters,highlightsthefollowingkeyyear...althflexiblespendingaccounts(HealthFSAs) . Manye...axesbyplacingfundsintheiremployer,shealthFSA.These...
(Date:11/24/2009)... Physician recruiting firm LocumTenens.com, a... is pleased to announce its agreement with VHA Inc...cians for locum tenens assignments. , ...009 -- Physician recruiting firm LocumTenens.co...fing, is pleased to announce its agreement with VH...
Breaking Medicine News(10 mins):Health News:Paying Tribute to Boxer Francisco 'Paco' Rodriguez 2Health News:When Holiday Meals Aren't a Gift 2Health News:The Right Tax Moves for Employees to Make Before Year-End 2Health News:The Right Tax Moves for Employees to Make Before Year-End 3Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2
...will upgrade their existing military hospitals to ... been decided to upgrade the hospitals in (the sou...ities," Vice Admiral surgeon Vijay K. Singh, direc...ion has been spent on buying new equipment like CT...
...adesh claim to have successfully carried out a hip...unthala Devi had slipped and broken her hipbone in...t month. Though her age was not conducive to a hip...ay. In a day or two, she would be made to walk wit...
...e children in California is overweight or at risk ...leased by a health insurance company.// The...geles County, which comprises 88 satellite cities....e, said the Blue Cross of California, a health ins...
...l was allegedly operated on her leg instead of her... of Jajpur, some 100 km from here, the// patient's... an unusual case of polio affecting the hand, but ...tira village. He said the doctors continued ...
... Jammu and Kashmir by humanitarian group Médecins ...nts suffered from psychological// distress and mor...ce since the beginning of the conflict. The...s the beginning of the conflict period. In ...
...nter researchers have found a new supplemental the...ls //can reduce pain, the potential for chronic pa... suffering from a common jaw disorder. The the...or do her job, and dental care provided little rel...
Other Medicine News:Health News:South India to Have Modern Military Hospitals 2Health News:Mental Health of Kashmiris Needs Urgent Attention: Survey 2Health News:New Supplemental Therapy for Common Jaw Disorder 2
(Date:11/24/2009)...v.24/PRNewswire-Asia-FirstCall/--LotusPharmaceutic...any")agrowingdeveloperand,producerofprescriptionsd...uctsinthePeople,sRepublicChina,todayreporteditwill...armaceuticaldelegation. ,, Time:November26-28...hengdu ,, TheBeijingdelegationfeaturesmoretha...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--ZimmerHoldings,Inc...patinginthe21stAnnualPiperJaffrayHealthCareConfere...sternTime. ,, Alivewebcastofthepresentationcanb...p://investor.zimmer.com .Thewebcastwillbearchivedf...pany ,, Foundedin1927andheadquarteredinWarsaw,...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Orexigen®Therape...yfocusedonthetreatmentofobesity,todayannouncedthat...any,sBoardofDirectorsgrantedaninducementstockoptio...sen,M.D.,itsnewlyappointedHeadoftheGlobalContraveP...ivestockoptiontotheextentpermittedbylawandhasanexe...
Breaking Medicine Technology:Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Research vessel Polarstern starts 24th Arctic season 8898 1Research vessel Polarstern starts 24th Arctic season 8898 2The Leukemia 26 Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense 49377 1The Leukemia 26 Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense 49377 2First World Congress on Positive Psychology Kicks Off Today With Talks by Two of the Worlds Most Renowned Psychologists Martin Seligman and Philip Zi 49373 1First World Congress on Positive Psychology Kicks Off Today With Talks by Two of the Worlds Most Renowned Psychologists Martin Seligman and Philip Zi 49373 2First World Congress on Positive Psychology Kicks Off Today With Talks by Two of the Worlds Most Renowned Psychologists Martin Seligman and Philip Zi 49373 3First World Congress on Positive Psychology Kicks Off Today With Talks by Two of the Worlds Most Renowned Psychologists Martin Seligman and Philip Zi 49373 4
...ESHIRE, Conn., Jan. 7 Alexion,Pharmaceuticals, In...hat it,has commenced dosing in the AEGIS study, a ...efficacy, and pharmacology of Soliris(R) (eculizum...xysmal nocturnal,hemoglobinuria (PNH). When fully ...n,s Pharmaceutical and Medical Device Administrati...
...CSON, Ariz., Jan. 4 ImaRx Therapeutics,Inc. (Nasd... (Transcranial,Ultrasound in Clinical SONolysis) c...ke., TUCSON Study Overview, The TUCSON trial is ...al trial. This trial is designed to evaluate the s...g doses of MRX-801 microbubbles and,ultrasound as ...
Other Medicine Technology:Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 2Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 3Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 4Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 5Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 6ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke 2ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke 3ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke 4
SYNCHRON LX4201
SYNCHRON CX® 1000 PRO Clinical System
SYNCHRON® CX500 PRO System
SYNCHRON LX® 2000 PRO
Medicine Products: